Altierre and Sirqul Announce Strategic Alliance to Help Shoppers Locate Items In-Store
Altierre Corp and Sirqul today announced a strategic global alliance at Retail World Congress in Madrid. The alliance brings together Altierre’s leading Internet of Things (IoT) platform and Electronic Shelf Labels (ESL) with Sirqul’s IoT platform and location-based Edysen technology to give retailers a smart, efficient solution for locating items and shoppers in their stores.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180416006619/en/
Technology from Altierre and Sirqul can help shoppers locate items in-store and direct them to complementary and promotional products (Photo: Business Wire)
By combining Altierre’s wireless in-store IoT platform and ESLs with Sirqul’s patented Edysen location intelligence and IoT platform, retailers can now transform the in-store experience and make individualized promotional offers to shoppers based on their exact indoor location, behavioral insight, and purchase/loyalty history.
Sirqul’s groundbreaking technology enables Altierre to deliver an Augmented Reality (AR) application. As a standalone solution or native inside the retailer’s loyalty app, the never seen before functionality allows shoppers to precisely locate specific items in-store while providing recommendations and promotional offers. Retailers will also take advantage of the new AR app to enable associates to pick and pack products for Buy Online and Pickup in Store, Ship from Store, and Curbside Delivery.
Sirqul’s technology can monitor shoppers’ with or without an app to view paths in the store, understand dwell times, and provide heat maps of store traffic to optimize staffing, store layouts, and product locations. Retailers are currently experimenting with existing technologies to accomplish these objectives, such as computer vision and video analytics. Sirqul’s solution is less expensive and more effective with a higher degree of accuracy.
“Online retailers have had a competitive advantage over brick and mortar retailers for too long,” said Rob Crane, Altierre’s Executive Vice President, Global Sales and Marketing. “By understanding a shopper’s location in the store, the location of items and fixtures and analyzing a shopper’s purchase history, we can deliver an application which makes intelligent recommendations to shoppers and then guides them around the store using AR, locating and promoting items individually to that shopper. This partnership will drive significant value for retailers and the solution is much greater than the sum of its parts, we’re very excited to debut this solution at the World Retail Congress and demonstrate it to such an elite group of Global Retail Leaders in Madrid.”
Leveraging AI to analyze shopper’s traffic patterns will help retailers optimize their planogram. Marrying this data with POS data will give retailers a granular picture of shopper activity, which they can leverage to optimize planograms on a store-by-store basis.
“Rich immersive experiences will make an immediate impact, turning visitors into loyal, repeat customers,” said Robert Frederick, CEO and President at Sirqul. “Digital transformation in-store, with or without an app, can now deliver on its promise to engage both the customer and associate with interactions that drive store optimization of floorplans, create personalized journeys, analyze and predict behavior, and ultimately increase revenue.”
Altierre Corp. is the only future proof wireless IoT system. The system’s ultra-low energy requirement, bi-directional messaging and solutions suite provide brick-and-mortar retailers with the same agility as online merchants to continuously monitor, detect, flag and seize net profit opportunities across all areas of the business. Altierre’s patented system performs flawlessly in any store environment regardless of temperature extremes, line-of-sight barriers or concurrent channel frequency activities. Incorporated in 2003, Altierre is headquartered in San Jose, Calif. For more information, visit: www.altierre.com
Sirqul (www.sirqul.com) provides an Engagement-as-a-Service IoT Platform with Smart Mesh network technology to drive engagement, operational efficiency rapid innovation and new revenue streams. At the foundation of Sirqul’s platform are 75 Services, 350 APIs, 3 distinct IoT hardware product offerings, and over 30 customizable native application templates for rapid deployment on a building block approach. Sirqul is – device, protocol and cloud agnostic – fostering an interoperable system for building future-proof solutions for retail, auto, cities, buildings, industrial, entertainment, and more.
The Blueshirt Group (for Altierre)
Jeff Fox, 415-828-8298
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Heidelberg Engineering Announces the CE-Marking of ANTERION21.9.2018 16:41 | Pressemelding
Heidelberg Engineering, the leader in diagnostic imaging known for the internationally-acclaimed SPECTRALIS ® retina and glaucoma platform, announces the CE-marking of ANTERION ® – an innovative platform designed to transform anterior segment diagnostics and workflow. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180921005442/en/ The new Heidelberg Engineering ANTERION® provides the most important anterior segment examinations and measurements in one modular, upgradeable platform. (Graphic: Business Wire) The new ANTERION provides the most important anterior segment examinations and measurements in one modular, upgradeable platform. It is a single, workflow-efficient solution that brings together corneal topography and tomography, anterior segment metrics, axial length measurement and IOL calculation to transform the day-to-day routine of busy practices and clinics. Heidelberg Engineering has leveraged its core OCT technolo
Florian Winterstein Becomes New CEO of Jedox21.9.2018 15:46 | Pressemelding
The supervisory board of Jedox AG, a leading vendor of business intelligence and enterprise planning software, has appointed Florian Winterstein as Chief Executive Officer (CEO) effective October 2, 2018. This nomination will support Jedox’s international growth and a new development phase initiated by its latest fund raising in April 2018 with Iris Capital, eCAPITAL entrepreneurial Partners AG and Wecken & Cie. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180921005416/en/ Florian Winterstein (Photo: Business Wire) With 25 years of experience in strategy consulting and leadership in software and service organizations, Winterstein brings to the company a valuable combination of expertise in cloud solutions, business development, and value creation for customers and partners. As former Chief Strategy Officer of BravoSolution, he positioned the software-as-a-service company as trendsetting digitalization partner, extending it
Takeda Receives Positive CHMP Opinion Recommending ALUNBRIG® (brigatinib) for the Treatment of ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib21.9.2018 13:30 | Pressemelding
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending the full approval of ALUNBRIG® (brigatinib) as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive (ALK+) advanced non-small cell lung cancer (NSCLC) previously treated with crizotinib. ALUNBRIG is a tyrosine kinase inhibitor (TKI) designed to target and inhibit the ALK mutation in NSCLC. Approximately three to five percent of NSCLC patients globally have the ALK mutation. If the CHMP opinion is affirmed, and the European Commission approves ALUNBRIG, it will become the only ALK inhibitor available in the European Union as a one tablet per day dose that can be taken with or without food. The randomized, global Phase 2 ALTA trial was designed to investigate the efficacy and safety of ALUNBRIG in patients with locally advanced or metastatic ALK+
Asda Selects HCL Technologies to Help Drive IT Transformation21.9.2018 12:16 | Pressemelding
HCL Technologies (HCL), a leading global technology company, today announced that it has been selected to help drive IT transformation at the UK’s third-largest grocery retailer, Asda. The three-year application services contract will see HCL transform Asda’s IT Application Services with a new DevOps delivery model to drive data and analytics and support back-office applications through the full lifecycle of development, testing and support. HCL will also build a central data management platform to enable Asda to improve its insight and analytics capabilities. Asda operates more than 600 stores across the UK, employing over 135,000 people. Asda wanted to adopt a more agile approach towards application development and testing. This would allow the company to respond faster to business requirements and reduce time to market, while driving better user experience and satisfaction. HCL was selected due to its extensive expertise in successfully delivering similar large scale IT transformati
Ipsen Receives Positive CHMP Opinion for Cabometyx® (Cabozantinib) for the Second-line Treatment of Patients with Hepatocellular Carcinoma (HCC)21.9.2018 05:30 | Pressemelding
Regulatory News: Ipsen (Euronext:IPN; ADR:IPSEY) announced today that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), provided a positive opinion for Cabometyx® (cabozantinib) as a monotherapy for the treatment of hepatocellular carcinoma (HCC) in adults who have been previously treated with sorafenib. The CHMP positive opinion will now be reviewed by the European Commission (EC), which has the authority to approve medicines for the European Union (EU). Alexandre Lebeaut, MD, Executive Vice President, R&D and Chief Scientific Officer, Ipsen, said: “The global burden of liver cancer is increasing and despite the recent introduction of new agents, it remains the second leading cause of cancer mortality worldwide. Following today’s positive CHMP opinion and if approved by the European Commission, Cabometyx ® as monotherapy will give patients with HCC a much-needed new oral therapeutic option.” Dr Lorenza Rimassa,
Quanergy Selected as Exclusive LiDAR Partner for VRCO21.9.2018 05:00 | Pressemelding
Quanergy Systems, Inc., a global leader in the design and development of solid state LiDAR sensors and smart sensing solutions, and VRCO, designer and manufacturer of the luxury high-end e-VTOL (electric Vertical Take-Off and Landing) craft, the NeoXcraft XP2, today announced that VRCO will exclusively use Quanergy’s S3 solid state LiDAR sensors in the testing and market release versions of the aircraft. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180920006036/en/ VRCO NeoXcraft XP2 with Quanergy S3 LiDAR Sensor (Graphic: Business Wire) The NeoXcraft XP2, which VRCO and the University of Derby unveiled in late 2017 and intend to launch in 2020, is a two-passenger e-VTOL high-speed land, air, and water capable craft. The craft can scan and memorize take-off locations and store the data for use on the next approach to the same location. Quanergy’s innovative S3 solid state LiDAR sensor will be used for downward and forward